Rosa William E, Epstein Andrew S, Lauria Tara, Qualters Kelley, Kapoor-Hintzen Neena, Knezevic Andrea, Egan Barbara, Levine Marcia, Koo Douglas Junwoo, Gandham Ashley, Nelson Judith E
Department of Psychiatry and Behavioral Sciences (W.E.R.), Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Medicine (A.S.E., D.J.K., B.E., J.E.N.), Memorial Sloan Kettering Cancer Center, New York, New York; Supportive Care Service (A.S.E., T.L., K.Q., N.K.H., D.J.K., J.E.N.), Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College (J.E.N.), New York, New York.
J Pain Symptom Manage. 2025 May;69(5):496-506. doi: 10.1016/j.jpainsymman.2025.02.008. Epub 2025 Feb 17.
Patients with advanced cancer discharged from the hospital with no plan for further disease-directed treatment (on 'best supportive care'; BSC) and without specialized palliative care at home are extremely vulnerable to end-of-life suffering and hospital readmission.
To assess preliminary outcomes of PATHS (Post-Acute Transition to Home with Supportive Care), a nurse practitioner-led telehealth intervention delivering proactive, intensive, specialized palliative care in the immediate two-week post-discharge period.
We conducted a single-arm prospective quality improvement evaluation of PATHS with patients ≥21 years with advanced solid tumor malignancies discharged from the hospital on BSC having initially declined hospice. Sociodemographic and illness characteristics, index hospital admission (IHA) and discharge data, and PATHS outcomes were descriptively analyzed. Competing-risks analysis provided cumulative incidence of hospital readmission following IHA discharge (primary outcome).
Patients (n = 30) had a median age of 67 years and were predominantly female (53%) and white (63%). Colorectal cancer was the most common diagnosis (30%) and pain the most common IHA reason (33%). The 30-day cumulative incidence of hospital readmission was 33% (95% CI: 16, 51) compared to a historical control rate of 43% (95% CI: 26, 59). No patient receiving timely hospice care at home was readmitted to the hospital. At PATHS completion, 11 patients (36%) had transitioned to hospice, nine of whom accepted a hospice referral during their first PATHS visit.
PATHS fills a substantive practice gap, potentially reducing end-of-life hospital readmissions while increasing home-based, specialized palliative care access for BSC patients with cancer approaching death after hospitalization.
晚期癌症患者出院时没有进一步疾病导向治疗计划(接受“最佳支持治疗”;BSC)且家中没有专业姑息治疗,极易遭受临终痛苦并再次入院。
评估PATHS(急性后期过渡到家庭支持治疗)的初步结果,这是一项由执业护士主导的远程医疗干预措施,在出院后的两周内提供主动、强化、专业的姑息治疗。
我们对PATHS进行了单臂前瞻性质量改进评估,研究对象为年龄≥21岁、因晚期实体瘤恶性肿瘤从医院出院且最初拒绝临终关怀的BSC患者。对社会人口统计学和疾病特征、首次住院(IHA)和出院数据以及PATHS结果进行了描述性分析。竞争风险分析提供了IHA出院后再次入院的累积发生率(主要结局)。
患者(n = 30)的中位年龄为67岁,主要为女性(53%)和白人(63%)。结直肠癌是最常见的诊断(30%),疼痛是最常见的IHA原因(33%)。再次入院的30天累积发生率为33%(95%CI:16,51),而历史对照率为43%(95%CI:26,59)。没有在家中接受及时临终关怀的患者再次入院。在PATHS结束时,11名患者(36%)已过渡到临终关怀,其中9人在首次PATHS就诊期间接受了临终关怀转诊。
PATHS填补了一个实质性的实践空白,可能减少临终时的再次入院,同时增加了对住院后接近死亡的BSC癌症患者的家庭专业姑息治疗机会。